---
figid: PMC7143295__ijerph-17-02078-g004
figlink: pmc/articles/PMC7143295/figure/ijerph-17-02078-f004/
number: Figure 4
caption: Mammalian target of rapamycin (mTOR) signaling pathway. mTOR is a subunit
  of two distinct multi-protein complexes, mTORC1 and mTORC2. Both mTORC1 and mTORC2
  can be activated in response to growth-factors stimulation, whereas mTORC2 is a
  major kinase that phosphorylates and activates Akt. The importance of mTORC1 and
  mTORC2 in regulation of multiple cell functions vital for development of cancer
  and their strong interaction with oncogenic pathways make mTOR an attractive target
  for therapeutic intervention. The mechanisms of action of currently available mTOR
  inhibitors are shown. Reproduced with permission from Zaytseva YY, Valentino JD,
  Gulhati P, Evers BM. mTOR inhibitors in cancer therapy. Cancer Letters. 2012, 319,
  1–7 [].
pmcid: PMC7143295
papertitle: 'Triple-Negative Breast Cancer: A Review of Conventional and Advanced
  Therapeutic Strategies.'
reftext: Mauricio A. Medina, et al. Int J Environ Res Public Health. 2020 Mar;17(6):2078.
pmc_ranked_result_index: '4766'
pathway_score: 0.9459289
filename: ijerph-17-02078-g004.jpg
figtitle: Mammalian target of rapamycin (mTOR) signaling pathway
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7143295__ijerph-17-02078-g004.html
  '@type': Dataset
  description: Mammalian target of rapamycin (mTOR) signaling pathway. mTOR is a subunit
    of two distinct multi-protein complexes, mTORC1 and mTORC2. Both mTORC1 and mTORC2
    can be activated in response to growth-factors stimulation, whereas mTORC2 is
    a major kinase that phosphorylates and activates Akt. The importance of mTORC1
    and mTORC2 in regulation of multiple cell functions vital for development of cancer
    and their strong interaction with oncogenic pathways make mTOR an attractive target
    for therapeutic intervention. The mechanisms of action of currently available
    mTOR inhibitors are shown. Reproduced with permission from Zaytseva YY, Valentino
    JD, Gulhati P, Evers BM. mTOR inhibitors in cancer therapy. Cancer Letters. 2012,
    319, 1–7 [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - MTOR
  - MLST8
  - RICTOR
  - ACTA1
  - ACTA2
  - ACTG1
  - ACTB
  - ACTC1
  - ACTG2
  - Rapamycin
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: P13K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: P13K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: P13K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: P13K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: P13K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: P13K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: P13K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: P13K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MLST8
  symbol: MLST8
  source: hgnc_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: RICTOR
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MLST8
  symbol: MLST8
  source: hgnc_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA1
  entrez: '58'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA2
  entrez: '59'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG1
  entrez: '71'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTB
  entrez: '60'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTC1
  entrez: '70'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG2
  entrez: '72'
chemicals:
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases: []
---
